The pressure is on for better quality, more granular customer data.
Putting the who, where and why of real-world studies into context.
Digital apps are more agile than longstanding solutions and allow tailored interrogation of data.
Awareness, Trial, and Usage tracking can be enhanced if technology updates it in real time.
Big data initiatives positioning the UK as a desirable location for R&D.
Information gleaned from data is the key to making health services safer, more efficient and cost effective.
Examining the reach, quantity and quality of medical and pharma company outputs.
Pharma must be prepared to work collaboratively to establish the best benefit-risk profiles and outcomes.
Sustainability and Transformation Plans present an opportunity for pharma to support research into mental health conditions.
